GT
BTMD icon

Glenmede Trust’s Biote Corp BTMD Stock Holding History

Glenmede Trust’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-30,318
Closed -$295K – 1331
2021
Q3 		$295K Buy
+30,318
New +$294K ﹤0.01% 1030

Other funds holding BTMD

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Glenmede Trust's BTMD Position: Q4 2021 in Review

Glenmede Trust sold out of Biote Corp (BTMD) in Q4 2021, closing a stake of 30,318 shares — an estimated $295K sold.

Glenmede Trust first reported a position in BTMD in Q3 2021 and held it in 1 quarter. The position peaked at $295K in Q3 2021. 78 funds tracked by Wall St. Rank hold BTMD as of Q4 2021.

  • Glenmede Trust reported no remaining Biote Corp position as of Q4 2021 after selling out during the quarter.
  • Glenmede Trust sold 30,318 Biote Corp shares in Q4 2021, an estimated $295K.
  • Glenmede Trust first reported a position in Biote Corp in Q3 2021 and held it in 1 quarter.
  • Glenmede Trust's Biote Corp position peaked at $295K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Biote Corp as of Q4 2021.

Based on Glenmede Trust's 13F filing for Q4 2021, filed 15 Feb 2022.